# Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection

> **NCT07593833** · — · NOT_YET_RECRUITING · sponsor: **Tongji Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Ovarian Neoplasms
- Ovarian Cancer
- Early Detection of Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection

## Key facts

- **NCT ID:** NCT07593833
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07593833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07593833, "Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT07593833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*